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Prevention of periodontal diseases, including gingivitis and periodontitis, has been defined as a 
multistage process with primary, secondary, and tertiary components.1 Primary prevention 
involves preventing inception of disease and includes the concept of health promotion and 
protection strategies. These health promotion strategies, aimed at enabling groups or 
individuals to control and improve their health, include providing oral hygiene education and 
protection strategies such as fluoridation. In developed nations, dentistry has been successful in 
these primary prevention areas. This success is illustrated by improvements in attitudes toward 
the importance of oral hygiene and the provision of fluoridated water supplies.2,3 Secondary 
disease prevention aims to limit the impact of disease by way of early diagnosis and treatment, 
thereby stopping disease progression in its earliest stages. The concept of tertiary disease 
prevention is focused on the rehabilitation of the functional limitations that arise due to the 
disabilities encountered after advanced disease and includes such things as implants and 
prosthetic restoration of missing teeth. 
Because the ultimate goal is to maintain the dentition over a lifetime in a state of health, 
comfort, and function in an esthetically pleasing presentation, this article focuses on the first 
two stages of periodontal disease prevention as they relate to gingivitis and periodontitis. 
Because these diseases are biofilm mediated and oral hygiene is important in all stages of 
prevention, certain concepts discussed here can and should be applied to all three phases of 
disease prevention. This article discusses risk assessment, mechanical plaque control, chemical 
plaque control, current clinical recommendations for optimal prevention, and future preventive 
strategies. 
Risk assessment as an aid in prevention 
The idea of applying risk assessment information to supportive periodontal care after thorough 
surgical or nonsurgical periodontal therapy is not new or untested. Axelsson and 
coworkers4,5,6 demonstrated that this approach essentially eliminates the recurrence 
of caries and periodontal disease. Until recently, however, there has not been any validated 
and generally accepted tool for risk assessment. Through the 1960s, the concept of varying 
susceptibility to periodontitis was not widely accepted because early epidemiologic studies 
suggested that the disease was essentially pandemic in adults.7,8 Subsequent experimental 
work on animals demonstrated variability in disease expression,9 and more precise human 
population studies showed substantially lower prevalence rates for moderate to advanced 
periodontitis.10 These findings strongly suggested that differing susceptibilities for periodontal 
disease existed within a population. Much work has been done since that time to define local, 
environmental, and genetic factors that place individuals at a higher risk for developing 
periodontitis.11,12,13,14 
A risk factor is defined as some aspect of personal behavior or lifestyle, an environmental 
exposure, or an inherited characteristic that based on epidemiologic evidence is known to be 
hazardous to one's health and well-being.15 The presence of a risk factor increases the 
probability of developing the disease and represents a possible target for prevention or 
therapy. Although it is beyond the scope of this article to review the evidence that has 
accumulated over the last 2 decades regarding identification of risk factors and their strength of 
association with periodontitis, there are several factors that have repeatedly been 
documented. Examples of such risk factors include cigarette smoking, uncontrolled diabetes, 
irregular dental care, and plaque in the presence of attachment loss. This article focuses on 
recent research efforts to quantify the risk assessment because this represents a major step 
forward in the attempt to tailor preventive strategies for individuals. 
As dentistry and periodontics begin to transition from a repair model of oral health care to a 
wellness model, the need to be able to predictably quantify levels of risk is crucial. In the last 
World Workshop of Periodontics, the consensus report on prevention stated that the 
incorporation of risk assessment models for prevention of periodontal disease is an important 
goal. The concept of continuous multilevel risk assessment has developed and has been 
promoted as an important, if not essential, factor in proper patient assessment as part of 
treatment planning and reassessment during maintenance.16 One of the consistent therapeutic 
goals in the American Academy of Periodontology's Parameters of Care is to reduce or 
eliminate contributing risk factors for gingivitis and periodontitis.17 Moreover, the latest 
American Academy of Periodontology position paper on periodontal maintenance recommends 
that dental professionals should counsel people on the control of risk factors.18 The actual 
assessment and application of risk levels in prevention and management of periodontitis, 
however, is in its infancy. Although there are odds ratios and relative risk levels published for a 
variety of exposures as a crude means to assess the importance of each factor, there is 
currently little to no information on the interactions of these different risk factors. Clearly, not 
all of the relevant risk factors have been uncovered. 
Recently, a few clinical risk assessment approaches or tools have been promoted in the 
literature. One tool is a relatively simple questionnaire19 that provides a vague but individual 
risk profile for the clinician and an educational tool for communication with the patient. A more 
sophisticated instrument employs a continuous multilevel risk assessment that incorporates the 
consideration of subject, tooth, and site risk evaluations.16 This approach generates functional 
diagrams that provide a more objective means of quantifying an individual's risk (Fig. 1).16 
Depending on the area of the polygon, a patient may fall into low-, moderate-, or high-risk 
categories. The patient's individual periodontal risk assessment is low if all parameters fall 
within the low-risk categories or if only one category in the moderate-risk range (Fig. 2). A 
moderate periodontal risk assessment shows at least two parameters in the moderate 
category, with a maximum of one parameter in the high-risk area (Fig. 3). A patient with a high 
periodontal risk assessment has at least two parameters in the high-risk category (Fig. 4). 
Although this model still needs to be validated, it provides an objective quantification of risk 
into three categories. This assessment could provide justification for more or less aggressive 
preventive care. 
 
Fig. 1. Functional diagram to evaluate the patient's risk for recurrence of periodontitis. Each vector represents one risk factor or 
indicator with an area of relatively low risk, an area of moderate risk, and an area of high risk for disease progression. All factors 
have to be evaluated together; therefore, the area of relatively low risk is found within the center circle of the polygon, 
whereas the area of high risk is found outside the periphery of the second ring in bold. Between the two rings in bold, there is 
the area of moderate risk. BL, bone loss; BOP, bleeding on probing; Envir., environment; FS, frequent smoker; NS, nonsmoker; 
PD, pocket depth; S, smoker; Syst./Gen., systemic/general. (From Lang NP, Bragger U, Salvi G, et al. 
Supportive periodontal therapy (SPT). In: Lindhe J, Karring T, Lang NP, editors. Clinical periodontology and implantology. 4th 
edition. Oxford (England): Blackwell Munksgaard; 2003. p. 788; with permission.) 
 
Fig. 2. Functional diagram of a low-risk maintenance patient. Bleeding on probing (BOP) is 15%, four residual pockets ≥5 mm are 
diagnosed, two teeth have been lost, the bone factor in relation to age is 0.25, no systemic factor is known, and the patient is a 
nonsmoker. BL, bone loss; Envir., environment; FS, frequent smoker; NS, nonsmoker; PD, pocket depth; S, smoker; Syst./Gen., 
systemic/general. (From Lang NP, Bragger U, Salvi G, et al. Supportive periodontal therapy (SPT). In: Lindhe J, Karring T, Lang NP, 
editors. Clinical periodontology and implantology. 4th edition. Oxford (England): Blackwell Munksgaard; 2003. p. 788; with 
permission.) 
 
 
Fig. 3. Functional diagram of a medium-risk maintenance patient. Bleeding on probing (BOP) is 9%, six residual pockets ≥5 mm 
are diagnosed, four teeth have been lost, the bone factor in relation to age is 0.75, the patient has type I diabetes mellitus, and 
the patient is a nonsmoker. BL, bone loss; Envir., environment; FS, frequent smoker; NS, nonsmoker; PD, pocket depth; S, 
smoker; Syst./Gen., systemic/general. (From Lang NP, Bragger U, Salvi G, et al. Supportive periodontal therapy (SPT). In: Lindhe 
J, Karring T, Lang NP, editors. Clinical periodontology and implantology. 4th edition. Oxford (England): Blackwell Munksgaard; 
2003. p. 799; with permission.) 
 
Fig. 4. Functional diagram of a high-risk maintenance patient. Bleeding on probing (BOP) is 32%, 10 residual pockets ≥5 mm are 
diagnosed, 10 teeth have been lost, the bone factor in relation to age is 1.25, no systemic factor is known, and the patient is an 
occasional smoker. BL, bone loss; Envir., environment; FS, frequent smoker; NS, nonsmoker; PD, pocket depth; S, smoker; 
Syst./Gen., systemic/general. (From Lang NP, Bragger U, Salvi G, et al. Supportive periodontal therapy (SPT). In: Lindhe J, Karring 
T, Lang NP, editors. Clinical periodontology and implantology. 4th edition. Oxford (England): Blackwell Munksgaard; 2003. p. 
799; with permission.) 
 
Using a different multifactorial model, Page and coworkers22 developed the “Periodontal Risk 
Calculator” (PRC). The PRC incorporates mathematic algorithms that are based on nine known 
risk factors: age, smoking history, diabetes diagnosis, history of periodontal surgery, pocket 
depth, furcation involvements, restorations or calculus below the gingival 
margin, radiographic bone height, and vertical bone lesions. This Web-based instrument can be 
accessed at http://www.previser.com, and to the authors' knowledge, provides the first 
validated tool to objectively quantify risk. Because risk assessments based on subjective expert 
opinion have been shown to vary too much to be useful in everyday clinical decision 
making [20], the development of the PRC may well represent a major step forward in the 
transition from the surgical/repair model of dentistry to the wellness or medical model of 
patient care. Data suggest that expert clinicians in the United States and Europe appear to base 
most of their risk assessment on severity of disease at presentation rather than on factors such 
as smoking, diabetic status, and poor oral hygiene.20 Moreover, it has been observed that “risk 
scores generated for individual patients by subjective expert clinician opinion are highly 
variable and could result in the misapplication of treatment for some patients”.21 
Overtreatment or undertreatment of periodontal diseases may be the result of subjectively 
forming such opinions. 
Using a clinical patient data set from the VA Dental Longitudinal Study of Oral Health and 
Disease, Page and coworkers22,23 retrospectively assigned risk scores to each of the 523 subjects 
on a 1 (lowest) to 5 (highest) risk scale using information from the baseline examination. They 
subsequently assessed radiographic bone loss and tooth loss over the next 15 years. The mean 
percentage of bone loss followed a consistent pattern from least bone loss in the low-risk 
category to greatest bone loss in the highest risk category (2<3<4<5). Several measures of tooth 
loss over time showed a similar relationship. Clearly, this approach to validation had 
weaknesses that included the retrospective nature of the study, the lack of enough low-risk 
subjects (periodontal risk assessment = 1) to allow for the full range of risk levels to be 
validated, and the lack of data on why teeth were lost. In addition, for teeth without 
periodontal disease at baseline, the PRC did not appear to discriminate between risk levels. This 
study, however, demonstrated the ability of the PRC to “predict” with accuracy and validity 
periodontal deterioration and even tooth loss for teeth with periodontal disease at baseline. 
In addition to providing a quick and objective risk assessment, the PRC provides a periodontal 
diagnosis, a quantitative disease score from 1 to 100, and treatment options based on the 
current American Academy of Periodontology standards of care. If this technology catches on, it 
may have a substantial impact on the dental profession. The PRC would provide a useful tool 
for individual patient assessment and may help sort out cost-effective treatments and even 
suggest rational approaches to preventive measures. Accurate and objective risk prediction 
should provide dentistry the ability to make serious strides in moving toward a wellness model 
of patient care. It has the potential to substantially improve the allocation of health care dollars 
by reducing the overtreatment of low-risk patients and applying more aggressive preventive 
strategies to high-risk patients. 
Mechanical plaque control 
Successful primary or secondary prevention is based on two major factors, the first being 
proper, thorough treatment during active therapy and the second being patient compliance 
with daily plaque removal and regular professional supportive care. Because other articles in 
this issue of the Dental Clinics of North America deal with active surgical and nonsurgical 
treatments to eliminate disease, the current authors confine themselves to addressing current 
concepts in primary prevention of gingivitis and periodontitis and the personal and professional 
supportive methods to avoid recurrence after active therapy is finished. The authors' premise is 
that proper and thorough active treatment means leaving the patient with a 
maintainable periodontium, which can be accomplished with nonsurgical therapy in the disease 
control phase of treatment or after the surgical corrective phase. 
There is overwhelming evidence for the direct cause-and-effect relationship between the 
formation and accumulation of supragingival plaque and the development of gingivitis. It is also 
generally accepted that the loss of attachment and alveolar bone that defines periodontitis is 
preceded by gingivalinflammation and subgingival plaque maturation. 
It has been estimated that in a periodontitis patient with a full complement of teeth (28 
teeth/168 sites) only 6% or less of these sites exhibit tissue destruction at any given time.24 
Although only a small percentage of gingivitis sites may progress to periodontitis, it still cannot 
be discerned which inflamed sites are actively breaking down. Traditionally, the default 
approach has been to try to eliminate all plaque-induced inflammation, particularly in subjects 
who have shown a susceptibility to a destructive periodontal inflammation. The first line of 
defense against plaque-induced gingivitis has always been daily meticulous mechanical plaque 
removal supplemented by periodic professional mechanical tooth cleaning. 
Toothbrushing: manual versus powered 
Toothbrushing has played the major role in daily plaque control in developed nations for over 
60 years. According to the Lemelson-MIT Invention Index at the Massachusetts Institute of 
Technology, when Americans were asked to list the five inventions that they believed they 
could not live without, the toothbrush was more appreciated than the car, the personal 
computer, the cell phone, and the microwave oven.24a 
Many novel manual toothbrush designs and methods of brushing have been described in the 
literature, with no one design or method showing a clear superiority. There is no consensus on 
the optimal frequency of toothbrushing, but it is clear that the average person is not very 
efficient or thorough in daily plaque removal.25 Hawkins et al.26 and Beals et al.27 showed that 
most subjects spend less than a minute brushing their teeth with a manual toothbrush. It 
therefore seems reasonable for clinicians to ask whether it is time to start recommending 
powered brushes with automatic timers to moderate- and high-risk patients. 
When Van der Weijden and coworkers28,29 performed professional plaque removal on subjects 
for varying duration using a manual or an oscillating/rotating powered brush, they 
demonstrated that manual brushing, even after 6 minutes, only removed 75% of the plaque 
that the powered brush removed in 1 minute. Although one can argue the applicability of these 
particular data to direct patient use, there are additional studies that suggest that the electric 
toothbrush may prove advantageous for some patients. Several long-term (6 months or more) 
randomized controlled clinical trials have shown clinical benefits for certain powered brush 
designs compared with a manual brush in different populations with different levels of oral 
hygiene instruction.30,31,32,33,34,35 The differences between manual and powered brushing are 
more evident when oral hygiene instruction is provided and reinforced during these long-term 
trials. 
In perhaps the most comprehensive 6-month comparative clinical trial between a manual and a 
powered brush (oscillating/rotating type), Haffajee and coworkers36,37 showed significantly 
better reduction in gingival index and attachment levels for the powered brush group, with 
mandibular and lingual surfaces showing the most benefit. They further demonstrated in both 
groups that a high level of personal supragingival plaque control had an unexpected and 
substantial beneficial effect on the subgingival flora. The decreased prevalence of periodontal 
pathogens from subgingival and supragingival plaque should lower the risk of periodontal 
disease initiation and recurrence. They further speculated that the lack of a significant 
microbiologic difference between the manual and the powered brush groups might be because 
the areas of greatest differences in clinical parameters (lingual and mandibular) were not the 
same areas that were sampled microbiologically (mesial-buccal site of each tooth). 
Recently, two systematic reviews were published that addressed the comparative efficacy and 
safety of manual versus powered toothbrushing. Sicilia and coworkers38 concluded that the 
counter-rotational and the oscillating/rotating brushes can be more beneficial than a manual 
toothbrush in reducing the levels of gingival bleeding. A Cochrane Review noted that no 
powered toothbrush designs except for the oscillating/rotating action were consistently 
superior to manual brushing. It was found that the oscillating/rotating brush achieves a modest 
reduction in plaque and gingivitis compared with manual toothbrushing and that it is safe to 
use.39 The long-term implications of these findings are unknown. 
There are limited data regarding the compliance of powered toothbrush use in periodontitis 
patients. Stalnacke and coworkers40 found a 62% rate of daily compliance by maintenance 
patients at least 3 years after obtaining a powered brush. Only 3% had stopped using the 
powered brush altogether. In a study that specifically assessed low-compliance periodontal 
maintenance patients, another group showed an improved level of plaque control over 12 to 36 
months in subjects using a powered brush.41 Additional long-term studies would be useful. 
More recently, McCracken et al.42 recruited a small population of untreated periodontitis 
patients into a short-term powered toothbrush compliance study. Using a microelectronic 
device within each brush to record duration and pressure, the investigators gained further 
insight into powered toothbrush home use. Subjects were informed that the device would 
measure toothbrush performance only. No details were given as to what this meant in terms of 
their compliance. McCracken et al.42 found that over 2 months of use, only about one third of 
these patients were truly compliant in using the brush for 2 minutes twice a day, nearly one 
third of the subjects overused the brush, and approximately one third substantially underused 
the brush. These data suggest that most but not all periodontitis patients using a powered 
brush are compliant. Patient education and motivation, as expected, play the greatest role in 
personal mechanical plaque control. 
The plaque removal efficacy of the powered brush appears to come primarily from more 
efficient plaque removal on buccal and lingual approximal surfaces, with the problem of 
interproximal plaque removal still unresolved.43 Clearly, although powered brushes are more 
efficient at plaque removal, maximum benefit can only be achieved by proper instruction and 
patient motivation. 
Interdental cleaning 
Based on current knowledge, it seems reasonable to conclude that some form of regular 
interdental cleaning is necessary to maintain periodontal health because no toothbrush 
effectively disrupts true interproximal plaque, particularly in the posterior dentition. In 
addition, there is a clear interdental site predilection for gingivitis, periodontitis, and smooth-
surface caries. Interdental areas truly are the key high-risk surfaces.44 
There are many different types of interdental cleaning aids, but the most widely recommended 
is dental floss or tape. Floss is most useful in the nonperiodontitis patient who has 
full interdental papillae and no exposed concave root surfaces. When used properly, it can 
penetrate the interproximal sulcus approximately 2 to 3 mm. Axelsson et al.45 recommended 
that flat, fluoridated dental tape be used before brushing with a fluoridated toothpaste in 
children and young adults. It is unfortunate that traditional manual flossing is not an easy skill 
for patients to learn; it has been reported that only 20% of subjects report effective flossing 
behavior.46 Even in those who have been adequately trained and who can demonstrate skill 
retention after 1 year, there is still a substantial drop-off in daily plaque removal with time.47 
Flossing forks, superfloss and, more recently, powered flossers have been introduced to make it 
easier for patients to clean interproximally. The studies that have been done on these 
interdental devices do not have enough statistical power to show anything but equivalence. 
Interproximal brushes are better alternatives for periodontitis maintenance patients who have 
lost interdental papillae height and who are in a secondary preventive stage.45 Interdental 
brushes come in a range of sizes. It seems reasonable to assume that the largest size that fits 
the space being deplaqued would be the most efficacious; however, this has not been proved.48 
Considering the range of sizes needed for any given patient, it may be best to choose the size 
that can be used in all high-risk sites. Advantages of this type of brush include the ability to 
deliver topical antimicrobials or fluorides to interproximal sites while mechanically removing 
plaque and to provide positive stimuli to the fibroblasts in the col area. This latter benefit is 
speculative and is an extrapolation from recent studies in a canine model.49,50,51 
Fluoridated triangular toothpicks have also proved to be an excellent way to deplaque the 
interproximal areas up to 2 to 3 mm subgingivally and have been recommended as part of a 
needs-related oral hygiene regimen for patients with treated periodontitis as part of 
a secondary prevention program.45 
Single-tufted brushes and rubber-tipped stimulators tend to be site specific. They are most 
often recommended for furcations, tipped teeth, the distals of terminal molars, or tooth 
surfaces directly adjacent to edentulous sites. 
Chemical plaque control 
Mouthrinses 
Chemical preventive agents have been incorporated into oral disease management for 
centuries; however, it is only recently that these adjunctive therapies have been scientifically 
studied. Recently, Addy52 wrote a brief, informative, and rather humorous review on antiseptic 
use in periodontal therapy. These agents should be viewed as adjuncts and not replacements 
for effective mechanical plaque control. They are preventive agents, not therapeutic agents. 
Given that many patients cannot maintain adequate levels of plaque control using mechanical 
oral hygiene methods alone, chemical plaque control has become a big business. Despite some 
over-reaching advertisements about the efficacy of some of the currently available antiseptics 
for plaque control, the dental profession can be thankful for the widespread public education 
that is occurring on the dangers of interproximal plaque. This section emphasizes developments 
in the area of chemical plaque control since the last World Workshop in Periodontics.53 
The biofilm inhibitory concentrations for a given antimicrobialare generally orders of magnitude 
higher than the standard minimal inhibitory concentrations determined for planktonic (free-
floating) organisms. A recent in vitro study compared the antimicrobial activity of three 
mouthrinses with planktonic bacteria and their corresponding monospecies biofilms.54 As 
anticipated, the bacteria contained in biofilms were shown to have a decreased susceptibility 
to antimicrobial agents versus those in planktonic form. The antimicrobial mouthrinses included 
in the study were an essential-oil (EO)-containing mouthrinse (Listerine Antiseptic; Pfizer, 
Morris Plains, New Jersey), an amine fluoride/stannous fluoride–containing mouthrinse 
(Meridol), a triclosan and polyvinylmethyl ether/maleic acid copolymer–containing mouthrinse 
(Plax), and a negative control (phosphate-buffered saline). All three mouthrinses produced 
statistically significant (99.99%) reductions in planktonic strains compared with the control. 
Effects on the biofilm forms of the organisms, however, were more variable. Exposure to 
Listerine Antiseptic produced statistically significant reductions compared with the control, 
whereas Plax (Colgate Palmolive [UK] Ltd., Guildford, United Kingdom) and Meridol (Wybert 
GmbH, Lorrach, Germany) produced much smaller reductions that were not statistically 
significant. These in vitro results provide a clear demonstration of the resistance to 
antimicrobial agents conferred by biofilms. The results also provide additional support for 
employment of tests using biofilms to more accurately assess the relative activities of 
antiplaque agents in vitro (although when tested in vivo, there are even more obstacles to 
overcome). 
The in vivo use of an EO-containing antiseptic mouthrinse has a long clinical history (Listerine). 
The active ingredient of this mouthrinse is a fixed combination of EOs (0.064% thymol, 0.092% 
eucalyptol, 0.060% methyl salicylate, and 0.042% menthol). Many short-term (4–6 weeks) and 
long-term (3–6 months) clinical studies have demonstrated the effectiveness of EO rinses in 
plaque and gingivitis reduction. Although the “gold standard” for antiplaque and antigingivitis 
mouthrinsing is still chlorhexidine,55,56 the use of an EO rinse as an adjunct to mechanical oral 
hygiene can be beneficial, particularly in the secondary preventive phase because it does not 
induce calculus formation, taste alteration, or extrinsic tooth stain like chlorhexidine.57,58,59 
In a 6-month supervised-use trial specifically designed to compare the antiplaque and 
antigingivitis efficacy of EO and chlorhexidine mouthrinses, Overholser et al.60 showed 
significant reduction in plaque formation and in gingivitis compared with a negative control. 
Although both mouthrinses had comparable antigingivitis effectiveness, the chlorhexidine 
mouthrinse was significantly more effective than the EO-containing mouthrinse in reducing 
plaque. In addition, the chlorhexidine group had more extrinsic tooth stain and calculus than 
the EO or the control group.60 Charles and coworkers61 recently presented similar results in a 6-
month randomized controlled clinical study on the antiplaque and the antigingivitis effects of a 
chlorhexidine or EO rinse compared with control. Although the patients were randomly 
assigned to the groups, it is difficult to discern how the observers remained masked to the 
treatments, given the obvious presence of stain and calculus. The investigators also stated that 
there was a statistically significant difference between the chlorhexidine group and the EO 
group at 3 months, but toward the end of the study (6 months), there was no difference. The 
chlorhexidine rinse group had significantly higher calculus formation and extrinsic tooth stain 
compared with the EO rinse group or the control group. 
Because the occurrence of extrinsic tooth stain and calculus deposits may limit patient 
compliance, especially for long-term use, chlorhexidine mouthrinses have greater utility when 
short-term plaque control is critical. This situation includes the postoperative phase 
following periodontal surgery, when mechanical oral hygiene is difficult. The use of an EO rinse 
is better suited as a long-term plaque-control adjunct for moderate- to high-risk patients 
for primary and secondary prevention. For patients with physical disabilities that limit their 
mechanical oral hygiene skills, a chlorhexidine spray may prove useful.52 
The literature presents few studies that compare the efficacy of toothbrushing with 
interproximal plaque control using dental flossing or interproximal dental brushing62,63,64 or 
antimicrobial mouthrinses.57,58 Sharma et al.58 and Bauroth et al.57 compared the efficacy of 
plaque removal using an EO-containing mouthrinse or dental flossing in addition to brushing. 
They included three groups in a parallel-arm, single-masked, randomized controlled clinical 
trial. The first group received the EO mouthrinse twice a day as an adjunct to the patient's 
regular twice daily brushing with a fluoride dentifrice, the second group was advised to floss 
once daily in conjunction with brushing, and the third group received a control mouthrinse to 
supplement brushing. The results showed significant improvement for the EO rinse and the 
dental floss group compared with baseline measurements. Reduction in the interproximal 
modified gingival index scores was “at least as good as” that provided by flossing. Although 
these studies were well controlled and well designed, the measurement of interproximal 
plaque seems problematic because the flossing group showed significantly less reduction 
compared with other studies that investigated the additional interproximal plaque reduction 
benefit comparing brushing alone to brushing and flossing.64,65,66,67,68 In other words, the 
positive control (brushing and flossing) was not as positive as one might have expected; the 
reason for this is not clear in the study. Possible factors could be the length of this study 
compared with others. Patient compliance may have waned by the first 3-month visit, leading 
to poor flossing technique or a decrease in patient motivation. It should also be noted that 
methods for measuring true interproximal plaque are limited. 
A follow-up study compared a combination of mechanical and chemical hygiene regimens. The 
experimental group was instructed to brush twice a day (B), floss daily (F), and rinse with the 
antiseptic twice daily (EO). This BFEO group represented optimal mechanical and chemical 
plaque control. A second group used a control mouthrinse (C) in conjunction with brushing and 
flossing (BFC group). A final group was assigned to brush and to use the placebo mouthrinse as 
a negative control (BC). A significant reduction in mean modified gingival index and plaque 
index was seen for the experimental group (BFEO) compared with the other two groups. The 
investigators suggested that the combined mechanical disruption of the interproximal plaque 
followed by the EO rinse provides a synergistic effect in plaque and gingivitis reduction due to 
better biofilm penetration. There was little comment on the low incremental reduction for 
interproximal mean plaque index and modified gingival index from the BC and BFC groups or on 
the sharp drop from 3 to 6 months in the BFC group interproximal scores. 
As promising as these data are, it would be even more helpful to carry out similar studies on 
moderate- to high-risk patients because it has been suggested that antiseptic rinsing is not cost-
effective for the general population. Recommending widespread antiseptic rinsing for the 
general population is essentially vast overtreatment to reduce disease only in the 
subpopulation of susceptible patients.52 
Toothpaste 
Although the use of chlorhexidine as a mouthrinse has demonstrated significant plaque 
reduction, the incorporation of this agent into a dentifrice has proved difficult due to the 
interaction between chlorhexidine and calcium ions or anionic detergents such as sodium lauryl 
sulfate.69,70 
The use of antigingivitis dentifrices has been recommended for primary prevention and as a 
maintenance measure as part of secondary prevention in treated and maintained periodontal 
patients. The addition of triclosan (a broad-spectrum phenol-derived antibacterial agent) to 
different dentifrice formulations has been studied in various short- and long-term trials. Volpe 
et al.71 reviewed the use of various combinations of triclosan in reducing plaque and gingivitis in 
susceptible individuals. 
One of the available combinations of triclosan is composed of 0.3% triclosan, 2.0% copolymer, 
and 0.243% sodium fluoride (Colgate Total; Colgate Palmolive Co., New York, New York). This 
combination was shown to alter the quality and composition of subgingival plaque.72,73 
A significant 5-year study by Cullinan et al.74 supported and expanded the previous findings. 
This double-blind controlled clinical trial examined the effect of the same triclosan formulation 
as the previous studies on the progression of periodontal disease in patients with attachment 
loss ≥2 mm. It was concluded that the use of such a dentifrice significantly slowed the 
progression of periodontal disease in those individuals with existing disease. The clinical effect 
of a triclosan-containing dentifrice indicates that after a periodontal pocket has developed in a 
susceptible individual, the use of such dentifrice slows the progression of further pocket 
development. The effectiveness of triclosan dentifrice as a primary preventive measure against 
periodontitis has not been demonstrated; however, it has been used to prevent gingivitis, 
which is the necessary precursor to periodontitis. 
One of the side effects of a triclosan dentifrice is tooth staining. A similar problem has been 
noted with more recent stable formulations of a stannous fluoride–containing dentifrice with 
proven antiplaque effects.75,76 
Irrigation 
The effect of supragingival oral irrigation in periodontal therapy is to flush away loosely 
attached bacteria present in the gingival crevice, thereby diminishing the potential for 
developing gingivitis. There is contradictory evidence about the usefulness of supragingival 
irrigation in reducing plaque formation. Although a few studies have shown some benefits of 
oral irrigation (professionally applied and as a part of a home care program), the benefits have 
been unimpressive.77 Recently, an improvement was demonstrated using this therapy at the 
clinical and subclinical level in a short-term daily home use study in periodontal patients. These 
results suggest that oral irrigation with water as part of a regular oral hygiene program can 
decrease the concentration of pro-inflammatory cytokinesin gingival fluids.78 Although these 
are promising findings, more work needs to be done before a strong recommendation can be 
made to add such a regimen to daily home care for these patients. One must weigh the benefit 
against the cost of the therapy. There is also the possibility of poor long-term compliance. 
Clinical considerations for optimal prevention 
For patients having resistance to periodontitis and who would thus be classified as low risk 
based on currently available risk prediction instruments, it is not clear how much mechanical 
and chemical preventive therapy represents overtreatment. Likewise, for primary or secondary 
prevention in moderate- to high-risk “susceptible” patients, there is very little understanding of 
what may constitute the minimal effective therapy. The best available evidence compels us to 
continue to try to achieve “complete” plaque control by whatever means are best suited for the 
patient. For a toothbrushing population such as in the United States, this means there is more 
need for education and motivation in needs-related personal and professional gingivalplaque 
removal (supra- and subgingivally), with an emphasis on interproximal plaque removal in high-
risk sites. Axelsson and colleagues44,45 suggest that encouraging patients to perform 
interproximal plaque control on the posterior “key risk teeth” before toothbrushing may be 
adequate in achieving prevention because the behavior is linked with an already well-
established brushing habit. In high-risk patients in a secondary prevention program, the authors 
believe it is wise to consider a powered toothbrush for home use. When there are no allergies 
or other contraindications, a personal chemical plaque control regimen with a triclosan-
containing toothpaste and perhaps an EO-containing mouthrinse twice daily would provide a 
cost-effective, evidence-based approach to prevention. Other adjunctive home care 
approaches for the high-risk patient include a dilute sodium hypochlorite solution (1 teaspoon 
household bleach/250 mL tap water) for subgingival irrigation as recommended by Slots et al.79 
As an adjunct to the professional supportive periodontal therapy, the use of a 1:9 ratio of 
povidone-iodine to water in the ultrasonic unit has also proved useful, particularly for 
advanced chronic or aggressive periodontitis cases.79 When implants are present, plastic-tipped 
ultrasonics are preferred and metal instruments must be avoided. 
Continuous multilevel risk assessment and management is now the standard of care. Clinicians 
must counsel patients on their risk profile and help them take decisive steps to reduce risk at 
each level.16 Perhaps the one area that could have the greatest overall public health benefit 
immediately is smoking cessation counseling. 
Every dentist should be well familiar with the five “A's” of smoking cessation (Box 1) and the 
five first-line pharmacotherapies approved by the Food and Drug Administration for smoking 
cessation (Table 1). Clinicians must be willing to guide patients through this process. There is a 
new current dental terminology code (D1320) that is available for reimbursement, and each 
year more insurance plans are reimbursing for this service. Because the prevalence 
for adolescent smoking has risen dramatically since 1990, clinicians need to be proactive in 
discouraging adolescent and preadolescent patients from starting smoking. It is estimated that 
over 3000 additional teens and preteens become regular tobacco users each day.80 It certainly 
makes sense for dental professionals to take a leading role in combating this chronic addiction 
because they see these patients more frequently than physicians. 
Box 1 
The five “A's” for brief intervention 
1. Ask about tobacco use. Identify and document tobacco use status for every 
patient at every visit. 
2. Advise to quit. In a clear, strong, and personalized manner, urge every tobacco 
user to quit. 
3. Assess willingness to make a quit attempt. Is the tobacco user willing to make 
a quit attempt at this time? 
4. Assist in quit attempt. For the patient willing to make a quit attempt, use 
counseling and pharmacotherapy to help him or her quit. 
5. Arrange follow-up. Schedule follow-up contact, preferably within the first 
week after the quit date. 
 
Table 1. Suggestions for the clinical use of first-line pharmacotherapies approved for smoking 
cessation by the Food and Drug Administration 
 
Pharmacotherapy Precautions/contraindications Side 
effects 
Dosage Duration Availability Cost/da 
Bupropion SR History of seizure or history of 
eating disorder 
Insomnia, 
dry 
mouth 
Begin 
treatment 
1–2 wk 
prequit 150 
mg 
1×/morning 
for 3 d then 
150 mg 2×/d 
7–12 wk 
(up to 6 
mo) 
Zyban (prescription 
only) 
$3.33 
Nicotine gum — Mouth 
soreness, 
dyspepsia 
1–24 cigs/d: 
2 mg gum 
(≤24 pcs/d) 
25+ cigs/d: 4 
mg gum 
(≤24 pcs/d) 
≤12 wk Nicorette/Nicorette 
Mint (OTC only) 
$6.25 for 
10 (2-mg) 
pieces, 
$6.87 for 
10 (4-mg) 
pieces 
Nicotine inhaler — Local 
irritation 
of mouth 
and 
throat 
6–16 
cartridges/d 
≤6 mo Nicotrol Inhaler 
(prescription only) 
$10.94 for 
10 
cartridges 
Nicotine nasal 
spray 
— Nasal 
irritation 
8–40 
doses/d 
3–6 mo Nicotrol NS 
(prescription only) 
$5.40 for 
12 doses 
Nicotine patch — Local skin 
reaction, 
insomnia 
21 mg/24 h 
then 14 
mg/24 h 
then 7 
mg/24 h 
4 wk 
then 2 
wk then 
2 wk 
Nicoderm CQ (OTC 
only) and generic 
patches 
(prescription and 
OTC) 
Brand 
name: 
$4.00–
$4.50b 
   
15 mg/16 h 8 wk Nicotrol (OTC only) 
 
Abbreviations: cigs, cigarettes; OTC, over the counter; pcs, pieces. 
Information contained within this table is not comprehensive. Please see package insert for additional information. 
aCosts are based on retail prices of medication purchased in April 2000 at a national chain pharmacy located in 
Madison, Wisconsin. 
bGeneric brands of the patch recently became available and may be less expensive. 
 
Finally, dental care providers must assess the patient's disease status each time he or she 
returns for supportive periodontal therapy. Clinicians must use the data available from the 
medical history review, risk assessment, and clinical examination, including radiographs when 
taken. As part of the supportive periodontal therapy rotations at Marquette University School 
of Dentistry, the students are given a laminated card that lists some specific criteria they should 
employ to assess the stability or instability of their maintenance patients. These criteria are 
listed in Box 2. Application of objective criteria such as these in the general practitioner's office 
may provide a more rational approach to appropriate referrals to the periodontist. Based on a 
recent retrospective survey of changes in referral patterns to periodontal offices over the past 
20 years, it seems that some guidelines are needed if the goal of helping the public to keep 
their teeth in a state of health, comfort, and function in an esthetically pleasing 
presentation81 is to be reached. 
Box 2 
Site- and patient-level criteria to consider in assessing the stability of 
periodontal maintenance patients 
Inflammation as measured by bleeding on probing 
Full mouth bleeding on probing >15% suggests instability 
Sites that consistently show bleeding on probing over time may be unstable 
Sites that consistently show no bleeding on probing are likely stable 
Probing depth measurements 
Sites with a probing depth increase of ≥2 mm from baseline or previous visit are 
considered unstable 
Number of significant periodontal pocket depths (10 or more sites with ≥4 mm 
probing depth are considered unstable) 
Probing depth ≥6 mm at any site is considered unstable 
Progressive gingival recession from baseline or previous charting 
Radiographic considerations 
Loss of crestal bone height based on vertical bite wings is considered unstable 
Consistent presence of crestal lamina dura suggests stability 
Patient-level considerations 
Poor hygiene in the presence of attachment loss plaque index >30% is 
considered unstable 
Smoking more than one-half pack per day is considered unstable 
Diabetes mellitus with HBA1c ≥9 is considered unstable 
High-stress events, divorce, loss of a loved one, and unemployment are 
considered unstable 
 
Future preventive strategies 
Vaccine development for periodontitis is a possible protection strategy for primary prevention. 
Different groups have been developing vaccines that target important surface structures of 
certain periodontopathogens. These surface structures include the fimbrial protein and 
hemagglutinating subunits necessary for adhesion and colonization of Porphyromonas 
gingivalis and the surface cysteine proteinases Arg- and Lys-gingipains that allow P gingivalis to 
bind to and degrade host tissues, causing destruction by way of a prostaglandin E2–dependent 
mechanism.82,83,84,85 
New drug delivery systems are also in development that should provide more cost-effective, 
slow-release antimicrobials and anti-inflammatory agents for primary prevention in high-risk 
subjects and secondary prevention in more moderate- to low-risk cases. The possibility of using 
these systems to deliver antimicrobial, anti-inflammatory, or immune-modulating agents is 
currently being tested.86,87 
Another somewhat futuristic approach to primary or secondary prevention involves introducing 
nonpathogenic bacterial competitor strains (bacterial replacement therapy) as a means to 
prevent the colonization and establishment of pathogenic strains of bacteria. To date, most 
work done in this area has been geared toward dental caries rather than periodontal disease; 
however, progress has been made in construction of a nonpathogenic Streptococcus 
mutans strain that can colonize the oral cavity but has no ability to produce acid due to 
a lactate dehydrogenase deletion mutation.88,89,90 These are just a few of the biologic therapies 
making their way into clinics. Considering how far we have come in 50 years, it is truly an 
exciting time to be a dentist. 
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